Clinical Trials
113 trialsReLUTH
Institut du Cancer de Montpellier - Val d'Aurelle
Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
Predicting Disease Progression and/or Recurrence in Cancer
Massachusetts General Hospital
Association Between Irrigation Fluid Absorption and Perioperative cfDNA Dynamics After TURBT
Lanzhou University Second Hospital
ALA /NSCLC
Ain Shams University
First-in Cancer-Type Phase I Study of FT536 for Recurrent WHO Grade 4 Astrocytoma
Masonic Cancer Center, University of Minnesota
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca
Virginia Commonwealth University
MIND-PANC
Shanghai Zhongshan Hospital
Tumor Budding and T1 Substaging in Urothelial Bladder Cancer
Assiut University
RECOMEND
Asan Medical Center
IFM/DFCI2009
University Hospital, Toulouse
Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
M.D. Anderson Cancer Center
Anakinra in Preventing Severe Chimeric Antigen Receptor T-Cell Related Encephalopathy Syndrome in Patients With Recurrent or Refractory Large B-cell Lymphoma
Jonsson Comprehensive Cancer Center
CAPIcorn
West German Study Group
REMRI
University of Eastern Finland
MONITOR-RCT
Odense University Hospital
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)
MPN Research Foundation
HYPERBOLIC
Università Vita-Salute San Raffaele
Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
Yale University
Clinical Trial of Avasopasem in Patients With Metastatic Hormone Receptor Positive Breast Cancer With Progression on a CDK 4/6 Inhibitor and Hormonal Therapy
The University of Texas Health Science Center at San Antonio
Liver Disease and Other Systemic Diseases
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
REBIMMUNE
Assistance Publique - Hôpitaux de Paris
PATHFINDERS
Universität Duisburg-Essen
Autologous Transplantation Combined With BCMA CAR-T in the Treatment of UHR-MM
Institute of Hematology & Blood Diseases Hospital, China
The Exploration of OX40 (CD134) Expression Levels in Sarcoma Specimens and Its Clinical Application in Prognosis Determination
Peking University People's Hospital
Omitting CTV for Primary Tumor in LS-SCLC
Sun Yat-sen University
Nezha
Second Xiangya Hospital of Central South University
REALM-Post
Shanghai Chest Hospital
GYN-ART
IRCCS San Raffaele
Pazopanib in Combination With PCI-24781 in Patients With Metastatic Solid Tumors
University of California, San Francisco
Clinicopathologic Characteristics, Progression, and Prognostic Analysis of IPNB
The First Hospital of Jilin University
The Associations of Psychological Stress With Therapy Efficacy and Prognosis of Lung Cancer (STRESS-LUNG)
Second Xiangya Hospital of Central South University
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Stanford University
COMBITEP
Institut Bergonié
BMT-03
University of Illinois at Chicago
Axitinib and Avelumab in Treating Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
M.D. Anderson Cancer Center
PROMISE
Centre hospitalier de l'Université de Montréal (CHUM)
MESOVAX
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy
Ain Shams University
Understanding Communication in Healthcare to Achieve Trust (U-CHAT)
St. Jude Children's Research Hospital
Venetoclax With High-dose Ibrutinib for CLL Progressing on Single Agent Ibrutinib
University of California, San Diego
FET-POPPING
UMC Utrecht
EVENET
AC Camargo Cancer Center
Tumor Cell Plasticity and Aggressiveness in Human Non-small Cell Lung Cancer
Casa Sollievo della Sofferenza IRCCS
Soluble B7-H3 as a Biomarker for Osteosarcoma
Peking University People's Hospital
ProCaB
Universitaire Ziekenhuizen KU Leuven
Fractionated Gemtuzumab Ozogamicin Followed by Non-engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia
Brown University
Biomarkers of Recurrence and Progression in Non-muscle Invasive Bladder Cancer
Wroclaw Medical University
SLNB After Neoadjuvant Treatment in Node Positive Patients
Clinical Hospital Center Rijeka